RecruitingNCT05928169

Determinants of Chronic Inflammatory Skin Disease Trajectories


Sponsor

University Hospital Schleswig-Holstein

Enrollment

1,000 participants

Start Date

May 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Although it is well known that the clinical expression and course of chronic inflammatory skin diseases are highly variable, there are insufficient epidemiological data on this, and the factors that determine the manifestation, clinical features and course are also largely unknown. There are currently no reliable markers that could predict or delineate patient subgroups to support patient management. The aim of this project is to identify clinical and molecular factors that correlate with disease, disease subtypes and progression through in-depth long-term clinical characterization of patients with chronic inflammatory skin diseases and examination of individual biomaterials.


Eligibility

Min Age: 0 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Topical and systemic drugs for people with alopecia areata, atopic dermatitis, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 0 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTopical and systemic drugs

Recruitment and follow-up will be independent on the type of treatment


Locations(1)

Department of Dermatology and Allergy, University Hospital Schleswig-Holstein

Kiel, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05928169


Related Trials